Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

[Development of antibodies for immunotherapy of Alzheimer's disease].

Matsumoto SE, Jin H, Takeda K, Hasegawa Y, Motoi Y, Hattori N, Tabira T.

Rinsho Shinkeigaku. 2012;52(11):1168-70. Japanese.

PMID:
23196552
2.

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A.

Immunotherapy. 2012 Feb;4(2):213-38. doi: 10.2217/imt.11.170. Review.

PMID:
22339463
3.

[Current trend of immunotherapy for Alzheimer's disease].

Matsumoto SE, Tabira T.

Nihon Rinsho. 2011 Sep;69(9):1628-32. Review. Japanese.

PMID:
21922765
4.

Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?

Li Y, Liu Y, Wang Z, Jiang Y.

Expert Opin Biol Ther. 2013 Nov;13(11):1515-22. doi: 10.1517/14712598.2013.838555. Epub 2013 Sep 22. Review.

PMID:
24053611
5.

Immunotherapy for Alzheimer's disease.

Wang W, Fan L, Xu D, Wen Z, Yu R, Ma Q.

Acta Biochim Biophys Sin (Shanghai). 2012 Oct;44(10):807-14. Epub 2012 Aug 16. Review.

PMID:
22899646
6.

Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.

Wang HC, Yu YZ, Liu S, Zhao M, Xu Q.

Vaccine. 2016 Apr 4;34(15):1758-66. doi: 10.1016/j.vaccine.2016.02.056. Epub 2016 Mar 2.

PMID:
26945100
7.

Recent advance in immunotherapies for Alzheimer disease: with special reference to DNA vaccination.

Okura Y, Matsumoto Y.

Hum Vaccin. 2009 Jun;5(6):373-80. Epub 2009 Jun 12. Review.

PMID:
19221518
8.

Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.

Cribbs DH.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):207-16. Review.

9.

Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.

Menéndez-González M, Pérez-Piñera P, Martínez-Rivera M, Muñiz AL, Vega JA.

Curr Pharm Des. 2011;17(5):508-20. Review.

PMID:
21375481
10.

Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?

Panza F, Logroscino G, Imbimbo BP, Solfrizzi V.

Curr Opin Psychiatry. 2014 Mar;27(2):128-37. doi: 10.1097/YCO.0000000000000041. Review.

PMID:
24445401
11.

Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab.

Panza F, Frisardi V, Imbimbo BP, Seripa D, Paris F, Santamato A, D'Onofrio G, Logroscino G, Pilotto A, Solfrizzi V.

Curr Alzheimer Res. 2011 Dec;8(8):808-17. Review.

PMID:
21592055
12.

Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.

Matsuo K, Okamoto H, Kawai Y, Quan YS, Kamiyama F, Hirobe S, Okada N, Nakagawa S.

J Neuroimmunol. 2014 Jan 15;266(1-2):1-11. doi: 10.1016/j.jneuroim.2013.11.002. Epub 2013 Nov 11.

PMID:
24315156
13.

Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.

Lemere CA.

Prog Brain Res. 2009;175:83-93. doi: 10.1016/S0079-6123(09)17506-4. Review.

14.
15.

Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.

Rasool S, Martinez-Coria H, Wu JW, LaFerla F, Glabe CG.

J Neurochem. 2013 Aug;126(4):473-82. doi: 10.1111/jnc.12305. Epub 2013 Jun 16.

16.

Novel approaches for immunotherapeutic intervention in Alzheimer's disease.

Vasilevko V, Cribbs DH.

Neurochem Int. 2006 Jul;49(2):113-26. Epub 2006 Jun 12. Review.

PMID:
16765487
17.

Immunotherapy for Alzheimer's disease.

Steinitz M.

Immunotherapy. 2009 May;1(3):461-9. doi: 10.2217/imt.09.3.

PMID:
20635962
18.

Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.

Panza F, Frisardi V, Imbimbo BP, D'Onofrio G, Pietrarossa G, Seripa D, Pilotto A, Solfrizzi V.

Immunotherapy. 2010 Nov;2(6):767-82. doi: 10.2217/imt.10.80. Review.

PMID:
21091109
19.

Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.

Minami SS, Sidahmed E, Aid S, Shimoji M, Niikura T, Mocchetti I, Rebeck GW, Prendergast JS, Dealwis C, Wetzel R, Bosetti F, Matsuoka Y, Hoe HS, Turner RS.

J Neuroinflammation. 2010 Sep 28;7:57. doi: 10.1186/1742-2094-7-57.

20.

DNA vaccine therapy for Alzheimer's disease: present status and future direction.

Okura Y, Matsumoto Y.

Rejuvenation Res. 2008 Apr;11(2):301-8. doi: 10.1089/rej.2007.0638. Review.

PMID:
18442321

Supplemental Content

Support Center